PubRank

G L Schaer

Author PubWeight™ 27.89‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. N Engl J Med 1989 2.45
2 Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure? Circulation 2001 2.05
3 The coronary circulation in human septic shock. Circulation 1986 1.83
4 Effect of 100% oxygen administration on infarct size and left ventricular function in a canine model of myocardial infarction and reperfusion. Am Heart J 1995 1.45
5 Does low individual operator coronary interventional procedural volume correlate with worse institutional procedural outcome? J Am Coll Cardiol 1997 1.41
6 Suppression of the renin-angiotensin system by intravenous digoxin in chronic congestive heart failure. Am J Med 1983 1.27
7 Percutaneous transmyocardial laser revascularisation for severe angina: the PACIFIC randomised trial. Potential Class Improvement From Intramyocardial Channels. Lancet 2000 1.22
8 Detection of renal blood flow abnormalities in septic and critically ill patients using a newly designed indwelling thermodilution renal vein catheter. Chest 1990 1.10
9 Captopril kinetics in chronic congestive heart failure. Clin Pharmacol Ther 1982 1.09
10 Norepinephrine alone versus norepinephrine plus low-dose dopamine: enhanced renal blood flow with combination pressor therapy. Crit Care Med 1985 1.08
11 Norepinephrine plus low-dose dopamine: a beneficial combination. Crit Care Med 1998 1.04
12 Cocaine-induced cardiovascular effects: lack of evidence for a central nervous system site of action based on hemodynamic studies with cocaine methiodide. J Cardiovasc Pharmacol 1999 0.95
13 Sodium and water balance in chronic congestive heart failure. J Clin Invest 1986 0.90
14 Association of hyponatremia with increased renin activity in chronic congestive heart failure: impact of diuretic therapy. Am J Cardiol 1983 0.86
15 Value of the American College of Cardiology/American Heart Association stenosis morphology classification for coronary interventions in the late 1990s. Am J Cardiol 1998 0.86
16 Evaluation of a long-acting converting enzyme inhibitor (enalapril) for the treatment of chronic congestive heart failure. J Am Coll Cardiol 1983 0.85
17 Poloxamer-188 as an adjunct to primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. Am J Cardiol 1996 0.83
18 Cocaine produces coronary artery vasoconstriction independent of an intact endothelium. Chest 1992 0.81
19 Assessment of residual coronary arterial stenosis after thrombolytic therapy during acute myocardial infarction. Am J Cardiol 1987 0.80
20 Effect of cocaine on the coronary circulation and systemic hemodynamics in dogs. J Am Coll Cardiol 1990 0.80
21 Estimation of angiotensin II receptor activity in chronic congestive heart failure. Am Heart J 1984 0.79
22 Determinants of infarct size after thrombolytic treatment in acute myocardial infarction. Am J Cardiol 1999 0.77
23 Additive myocardial depressant effects of cocaine and ethanol. Am Heart J 1992 0.77
24 Cardiac endothelin release and infarct size, myocardial blood flow, and ventricular function in canine infarction and reperfusion. J Investig Med 1996 0.77
25 Fluosol in myocardial reperfusion injury. J Am Coll Cardiol 1995 0.75
26 If invasive functional testing is so great, why aren't we doing it routinely? Catheter Cardiovasc Interv 2001 0.75
27 Excimer laser ablation before autoperfusion balloon inflation: a novel therapeutic approach to high grade stenoses in vessels supplying substantial myocardium at risk. Cathet Cardiovasc Diagn 1992 0.75
28 Role of the sympathetic nervous system in the cardiovascular effects of cocaine. NIDA Res Monogr 1991 0.75